www.diseases-diagnosis.com Homepage Diseases Symptoms Diseases Diagnosis Diseases Treatment Diseases Living Care Diseases Prevention Diseases Research
www
Search
March 26, 2016
Table of Contents

1 Introduction
Alkermes (company)

Wikipedia

 

Alkermes, Inc. () is a pharmaceutical company headquartered in Waltham, Massachusetts with a manufacturing facility in Wilmington , Ohio. Alexander Rich, MD is the founder and director since 1987. The company focuses on drug delivery technologies, including "long-acting" or "extended release" formulations of injectable and inhaled drugs. The technology has currently been applied to "small molecule" type drugs, and peptide hormones. Typically, Alkermes applies its technology to an active ingredient owned by a partner company, although it is pursuing the development of at least one proprietary drug as well.

Their main product is Risperdal Consta , which is a long acting version of Johnson & Johnson's Risperidone. The drug is an atypical antipsychotic used in the treatment of schizophrenia. On April 13, 2006, Alkermes and Cephalon, Inc. received Food and Drug Administration approval of Vivitrol (formerly Vivitrex ) for the treatment of alcohol dependence .

Eli Lilly and Company is working with Alkermes to develop a new version of inhaled insulin for type 1 diabetics , and an extended release formulation of Parathyroid hormone to treat osteoporosis. Both companies are also collaborating with Amylin to develop and market a long-acting version of Amylin's Byetta called Bydureon (Generic name: Exenatide LAR ) for the treatment of type 2 diabetes .

From 1999 to 2004, Alkermes and Genentech marketed Nutropin Depot (long acting somatropin for growth hormone deficiency), but the product was withdrawn due to high manufacturing costs. Currently, Alkermes and Lilly are developing an inhaled version of the hormone.

Independently, Alkermes is pursuing an inhaled version of epinephrine for anaphylaxis (allergic shock).





  • Alkermes, Inc.



This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Alkermes (company)".


Last Modified:   2010-11-29


Search
All informatin on the site is © www.diseases-diagnosis.com 2002-2011. Last revised: January 2, 2011
Are you interested in our site or/and want to use our information? please read how to contact us and our copyrights.
To let us provide you with high quality information, you can help us by making a more or less donation: